Developing a sprayable drug delivery system for the local delivery of nanoparticles in glioblastoma multiforme
Glioblastoma multiforme (GBM) is a World Health Organisation classified grade 4 tumour with a dismal median survival time of 14 months from diagnosis and a 16% 2-year survival rate. Current treatment consists of debulking surgery followed by concurrent radiotherapy and temozolomide chemotherapy. Rel...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/64553/ |